Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.

The Journal of antimicrobial chemotherapy - 1 Jul 1996

Ballestero S, Fernández-Rodríguez A, Villaverde R, Escobar H, Pérez-Díaz J C, Baquero F

Abstract excerpt

The evolution of imipenem resistance was evaluated in Pseudomonas aeruginosa sequentially isolated from 42 patients with cystic fibrosis. Susceptibility was determined using a commercial microdilution system and imipenem resistance was confirmed by the agar dilution technique. Resistance to imipenem increased during the years from 1988 to 1992. A total of 12 patients (28.5%) carried resistant strains (11.6% of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Infant

Share to Infant, Newborn

Share to Phenotype

Share to Species Specificity

Source

Identifiers

PMID: 8858455
DOI: 10.1093/jac/38.1.39

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.PMID 8858455Read ↗

Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey.Semantic proximity Read ↗

Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.Semantic proximity Read ↗

Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.Semantic proximity Read ↗

Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.Semantic proximity Read ↗

Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.Semantic proximity Read ↗

Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.Semantic proximity Read ↗

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.Semantic proximity Read ↗

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.Semantic proximity Read ↗

Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.Semantic proximity Read ↗

OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China.Semantic proximity Read ↗

Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.Semantic proximity Read ↗

Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.